|
Exhibit
10.1
SYNTROLEUM
CORPORATION
STOCK PURCHASE
AGREEMENT
April 11,
2005
TABLE OF
CONTENTS
|
|
|
|
|
| |
|
|
|
Page
|
| SECTION 1. AUTHORIZATION AND SALE OF COMMON STOCK |
|
1 |
|
1.1
|
|
Authorization |
|
1 |
|
1.2
|
|
Sale of
the Shares |
|
1 |
|
|
| SECTION 2. CLOSING DATE; DELIVERY |
|
1 |
|
2.1
|
|
Closing |
|
1 |
|
2.2
|
|
Delivery |
|
1 |
|
|
| SECTION 3. REPRESENTATIONS AND WARRANTIES OF THE
COMPANY |
|
1 |
|
3.1
|
|
Organization and Standing; Subsidiaries; Charter and
Bylaws |
|
1 |
|
3.2
|
|
Capitalization |
|
2 |
|
3.3
|
|
Authorization |
|
3 |
|
3.4
|
|
SEC
Reports |
|
3 |
|
3.5
|
|
No
Conflicts |
|
4 |
|
3.6
|
|
Approvals |
|
4 |
|
3.7
|
|
Offering |
|
4 |
|
3.8
|
|
Litigation |
|
4 |
|
3.9
|
|
Brokers
or Finders |
|
5 |
|
3.10
|
|
Limitation on Representations |
|
5 |
|
|
| SECTION 4. REPRESENTATIONS AND WARRANTIES OF THE
PURCHASER |
|
5 |
|
4.1
|
|
Investment |
|
5 |
|
4.2
|
|
Authorization |
|
5 |
|
4.3
|
|
Litigation, etc. |
|
6 |
|
4.4
|
|
Governmental Consent, etc. |
|
6 |
|
4.5
|
|
Brokers
or Finders |
|
6 |
|
|
| SECTION 5. CONDITIONS TO CLOSING BY THE PURCHASER |
|
6 |
|
5.1
|
|
Representations and Warranties Correct |
|
6 |
|
5.2
|
|
Covenants |
|
6 |
|
5.3
|
|
Effectiveness of Registration Statement |
|
6 |
|
5.4
|
|
Approval
of Inclusion on the Nasdaq National Market |
|
6 |
|
5.5
|
|
No Legal
Order Pending |
|
6 |
|
5.6
|
|
No Law
Prohibiting or Restricting Such Sale |
|
7 |
|
5.7
|
|
Compliance Certificate |
|
7 |
|
5.8
|
|
Opinion
of Company’s Counsel |
|
7 |
|
5.9
|
|
Good
Standing Certificate |
|
7 |
|
5.10
|
|
Secretary’s Certificate |
|
7 |
|
|
| SECTION 6. CONDITIONS TO CLOSING BY THE COMPANY |
|
7 |
|
6.1
|
|
Representations |
|
7 |
|
6.2
|
|
Covenants |
|
7 |
i
|
|
|
|
|
|
6.3
|
|
Compliance Certificate |
|
7 |
|
6.4
|
|
Effectiveness of Registration Statement |
|
8 |
|
6.5
|
|
No Legal
Order Pending |
|
8 |
|
6.6
|
|
No Law
Prohibiting or Restricting Such Sale |
|
8 |
|
|
| SECTION 7. COVENANTS |
|
8 |
|
7.1
|
|
Fulfillment of Closing Conditions |
|
8 |
|
7.2
|
|
Confidentiality |
|
8 |
|
7.3
|
|
Publicity |
|
9 |
|
7.4
|
|
Restriction on Sale of Securities |
|
9 |
|
7.5
|
|
Registration Statement |
|
9 |
|
|
| SECTION 8. MISCELLANEOUS |
|
9 |
|
8.1
|
|
Governing
Law |
|
9 |
|
8.2
|
|
Survival |
|
9 |
|
8.3
|
|
Successors and Assigns |
|
10 |
|
8.4
|
|
Entire
Agreement; Amendment |
|
10 |
|
8.5
|
|
Costs and
Expenses |
|
10 |
|
8.6
|
|
Notices,
etc |
|
10 |
|
8.7
|
|
Delays or
Omissions |
|
10 |
|
8.8
|
|
Severability |
|
11 |
|
8.9
|
|
Titles
and Subtitles |
|
11 |
|
8.10
|
|
Counterparts |
|
11 |
|
8.11
|
|
Construction |
|
11 |
|
8.12
|
|
Interpretation |
|
11 |
|
8.13
|
|
Definitions |
|
11 |
|
8.14
|
|
Facsimile
Signatures |
|
12 |
|
| EXHIBITS |
|
| A — Form of
Opinion of Baker Botts L.L.P. |
ii
STOCK PURCHASE
AGREEMENT
This Agreement is entered
into effective as of April 11, 2005 by and between Syntroleum
Corporation, a Delaware corporation (the “Company”),
and Dorset Group Corporation, a Panama corporation (the
“Purchaser”).
SECTION 1.
AUTHORIZATION AND SALE OF
COMMON STOCK
1.1 Authorization
. The Company has authorized the sale and issuance at the
Closing (as hereinafter defined) of 1,000,000 shares (the
“Shares”) of its common stock, par value $.01 per share
(“Common Stock”).
1.2 Sale of the
Shares . Subject to the terms and conditions hereof, the
Purchaser will buy from the Company, and the Company will issue and
sell to the Purchaser, the Shares for a purchase price per Share of
$10.00 (for an aggregate purchase price of $10,000,000.00 for all
of the Shares).
SECTION 2.
CLOSING DATE;
DELIVERY
2.1 Closing .
The closing of the purchase and sale of the Shares hereunder shall
be held at Syntroleum Corporation, 4322 South 49th West Avenue,
Tulsa, Oklahoma 74107, on the first Business Day following the day
on which the closing conditions set forth in Sections 5 and 6
hereof have been fulfilled (the “Closing”), or at such
other time and place upon which the Company and the Purchaser
mutually agree upon orally or in writing (the date of the Closing
is hereinafter referred to as the “Closing
Date”).
2.2 Delivery .
At the Closing, the Company will deliver to the Purchaser a
certificate or certificates, registered in the Purchaser’s
name, representing the Shares, against payment of the purchase
price therefor, by wire transfer to the Company in accordance with
its instructions.
SECTION 3.
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
Except as set forth on the
disclosure schedule prepared by the Company and delivered to the
Purchaser, dated as of the date hereof (the “Disclosure
Schedule”), the Company represents and warrants to the
Purchaser both as of the date hereof and again as of the Closing as
follows:
3.1 Organization and
Standing; Subsidiaries; Charter and Bylaws . The Company
and each of its Subsidiaries (as hereinafter defined) is a
corporation, partnership or limited liability company duly
organized, existing and in good standing under the laws of the
jurisdiction of its incorporation or organization. The Company and
each of its Subsidiaries has all requisite corporate, partnership
or limited liability company power and authority to own and operate
their respective properties and assets, and to carry on their
business as presently
1
conducted. The Company and each of its
Subsidiaries currently is qualified to do business in each
jurisdiction where the failure to be so qualified has not had and
would not reasonably be expected to have, individually or in the
aggregate, a material adverse effect on the assets, liabilities,
financial condition, operating results or business of the Company
and its Subsidiaries, taken as a whole (a “Material Adverse
Effect”). The Company has made available to the Purchaser a
true, correct and complete copy of the Company’s Certificate
of Incorporation, as in full force and effect on the date hereof
(the “Charter”), and a true, correct and complete copy
of the Company’s Bylaws as in full force and effect on the
date hereof (the “Bylaws”).
3.2 Capitalization
. The authorized capital stock of the Company consists of
155,000,000 shares, 150,000,000 shares of which are designated as
Common Stock, 250,000 shares of which are designated as Series A
Junior Participating Preferred Stock, par value $.01 per share
(“Series A Junior Preferred Stock”), and 4,750,000
shares of which is undesignated preferred stock, par value $.01 per
share (“Undesignated Stock”). As of April 6, 2005,
there were 54,297,187 shares of Common Stock outstanding and there
were no shares of Series A Junior Preferred Stock or Undesignated
Stock outstanding. The outstanding shares of the Company’s
capital stock have been duly authorized and validly issued and are
fully paid and nonassessable. As of the date hereof, (i) an
aggregate of 5,000,000 shares are reserved for issuance under the
Company’s 1993 Stock Option and Incentive Plan, and 4,115,249
shares of Common Stock are issuable pursuant to outstanding stock
options and restricted stock granted pursuant to the
Company’s 1993 Stock Option and Incentive Plan, (ii) an
aggregate of 395,370 shares (one percent of the number of shares of
Common Stock outstanding on January 1, 2005) are reserved for
issuance under the Company’s Stock Option Plan for Outside
Directors, and 160,665 shares of Common Stock are issuable pursuant
to outstanding stock options granted pursuant to the
Company’s Stock Option Plan for Outside Directors, (iii) an
aggregate of 1,025,198 shares are issuable pursuant to stock
options granted to Company consultants and officers outside of the
Company’s 1993 Stock Option and Incentive Plan, (iv) an
aggregate of 267,850 shares are reserved for issuance under the SLH
Corporation 1997 Stock Incentive Plan, (v) an aggregate of
1,552,000 shares of Common Stock are reserved for issuance pursuant
to the Company’s outstanding publicly traded warrants issued
on November 4, 2003, (vi) an aggregate of 887,400 shares of Common
Stock are reserved for issuance pursuant to the Company’s
outstanding publicly traded warrants issued on May 26, 2004, (vii)
an aggregate of 1,036,250 shares of Common Stock are reserved for
issuance pursuant to outstanding warrants issued to Company
consultants, (viii) an aggregate of 68,000 shares of Common Stock
are issuable pursuant to outstanding stock options granted to
Company employees pursuant to the Company’s 2005 Stock
Incentive Plan, which will be submitted for stockholder approval at
the Company’s 2005 annual meeting of stockholders (the
“2005 Annual Meeting”), (ix) a number of shares of
Common Stock equal to 1% of the amount of funds committed by
investors to the Company to be used to secure rights to stranded
oil and gas fields with associated oil and other hydrocarbons (the
“Stranded Gas Venture”) are issuable in accordance with
Amendment No. 4 to the Company’s Letter Agreement dated
October 3, 2003 with TI Capital Management (the “Consulting
Agreement Amendment”), which will be submitted for
stockholder approval at the 2005 Annual Meeting and (x) an
aggregate of 1,000,000 shares of Common Stock, plus a number of
shares of Common Stock equal to 1% of the amount of funds committed
by investors to the Stranded Gas Venture divided by a value per
warrant to purchase one share determined using a Black-Scholes
methodology that takes into account the expected holding period of
the warrant, current interest rates, the volatility of the Common
Stock over the prior year and the
2
market price of the Common Stock on the
date of issuance, are issuable pursuant to warrants that may be
issued in accordance with the Consulting Agreement Amendment, which
will be submitted for stockholder approval at the 2005 Annual
Meeting. Each outstanding share of Common Stock carries a stock
purchase right, which rights entitle the holder to buy one
one-hundredth of a share of junior preferred stock at a price of
$20.8333 per one one-hundredth of a share pursuant to the
provisions of the Company’s Second Amended and Restated
Rights Agreement dated as of October 24, 2004. Except as described
in this Agreement or in the Disclosure Schedule, there are no other
options, warrants, conversion privileges or other contractual
rights presently outstanding to purchase or otherwise acquire any
authorized but unissued shares of the Company’s capital stock
or other securities.
3.3 Authorization
. The Company has all requisite corporate power and authority
to execute and deliver this Agreement, to sell and issue the Shares
hereunder and to carry out and perform its obligations under the
terms of this Agreement. All corporate action on the part of the
Company, its directors and its stockholders necessary for the
authorization, execution, delivery and performance of this
Agreement by the Company, the authorization, sale, issuance and
delivery of the Shares and the performance of all of the
Company’s obligations hereunder has been taken or will have
been taken prior to the Closing. This Agreement constitutes the
valid and binding obligation of the Company, enforceable in
accordance with its terms, except as such enforcement is subject to
the effect of (i) any applicable bankruptcy, insolvency,
reorganization or other laws relating to or affecting
creditors’ rights generally, and (ii) general principles of
equity (regardless of whether such enforceability is considered in
a proceeding in equity or at law). Upon issuance in accordance with
the provisions of this Agreement, the Shares will be validly
issued, fully paid and nonassessable. The issuance and sale of the
Shares contemplated hereby will not give rise to any preemptive
rights or rights of first refusal on behalf of any
person.
3.4 SEC Reports
. The Company has previously made available to the Purchaser
true and complete copies of its (i) Annual Report on Form 10-K for
its fiscal year ended December 31, 2004, (ii) Proxy Statement for
the 2005 Annual Meeting of Stockholders filed on March 30, 2005,
(iii) Current Reports on Form 8-K filed on January 5, 2005, January
19, 2005, January 28, 2005, February 1, 2005, February 17, 2005,
March 8, 2005, March 21, 2005 and April 1, 2005 and (iv) any other
reports or registration statements filed by the Company with the
Commission since January 1, 2005, except for preliminary material,
which are all the documents that the Company was required to file
since that date (collectively, the “SEC Reports”). As
of their respective dates, the SEC Reports complied as to form in
all material respects with the requirements of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”),
and the rules and regulations of the Commission thereunder
applicable to such SEC Reports. As of their respective dates, the
SEC Reports, when read together with previously filed SEC Reports,
did not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements contained
therein, in light of the circumstances under which they were made,
not misleading, except as updated, corrected or superseded by
subsequently filed SEC Reports. Except as may be indicated therein
or in the notes thereto, the audited consolidated financial
statements and unaudited interim financial statements of the
Company included in the SEC Reports comply as to form in all
material respects with applicable accounting requirements and with
the published rules and regulations of the Commission with respect
thereto, have been prepared in accordance with generally accepted
accounting principles
3
applied on a consistent basis throughout
the periods covered thereby and fairly present in all material
respects the financial condition of the Company as of the dates
indicated and the results of operations, changes in
stockholders’ equity and cash flows of the Company for the
period indicated. Since December 31, 2004, there has been no change
in the assets, liabilities, financial condition, operating results
or business of the Company and its Subsidiaries, taken as a whole,
from that reflected in the audited consolidated financial
statements and unaudited interim financial statements of the
Company included in the SEC reports, except as set forth in the
Disclosure Schedule or changes in the ordinary course of business
that have not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect.
3.5 No Conflicts
. The execution, delivery and performance of this Agreement,
including the issuance of the Shares, have not resulted and will
not (i) result in any violation of or conflict with, or constitute
a default under, the Company’s Charter or Bylaws, (ii) result
in any violation of or conflict with, or constitute a material
default under, any mortgage, indebtedness, lease, indenture,
contract, agreement, license, instrument, judgment, order, decree,
statute, law, ordinance, rule or regulation to which the Company or
any of its Subsidiaries is party or otherwise subject to (subject
to any required notices or filings with the NNM (as hereinafter
defined) and such consents, approvals, authorizations, orders,
registrations or qualifications as may be required under state
securities or Blue Sky laws in connection with the issuance by the
Company of the Shares and the purchase of the Shares by the
Purchaser in the manner contemplated herein and in the Final
Prospectus and as have not had and would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse
Effect), or (iii) result in the creation of any mortgage, pledge,
lien, encumbrance or charge upon any of the properties or assets of
the Company or any of its Subsidiaries, except in the case of
clauses (ii) or (iii) as has not had and would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect.
3.6 Approvals .
The Securities and Exchange Commission (the
“Commission”) has issued an order under the Securities
Act of 1933, as amended (the “Securities Act”),
declaring the Registration Statement effective, and no other
consent, approval, authorization, order, registration or
qualification of or with any Governmental Authority (as hereinafter
defined) is required for the offer and sale of the Shares to the
Purchaser, or the consummation by the Company of the transactions
contemplated by this Agreement and the Final Prospectus (as
hereinafter defined), except such consents, approvals,
authorizations, orders, registrations or qualifications as may be
required under state securities or Blue Sky laws in connection with
the issuance by the Company of the Shares and the purchase of the
Shares by the Purchaser in the manner contemplated herein and in
the Final Prospectus and as have not had and would not reasonably
be expected to have, individually or in the aggregate, a Material
Adverse Effect.
3.7 Offering .
To the best of the Company’s knowledge, the Commission has
not issued any order preventing or suspending the use of the Base
Prospectus (as hereinafter defined).
3.8 Litigation
. There is no action, suit, proceeding or investigation pending
or, to the Company’s knowledge, currently threatened against
the Company or any Subsidiary of the Company that questions the
validity of this Agreement or the right of the Company to
enter
4
into such agreement, or to consummate
the transactions contemplated hereby, or that would reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect or that would reasonably be expected to materially
adversely affect the Company’s ability to consummate the
transaction contemplated hereby.
3.9 Brokers or
Finders . The Company has not incurred, and will not incur,
directly or indirectly, as a result of any action taken by the
Company, any liability for brokerage or finders’ fees or
agents’ commissions or any similar charge in connection with
this Agreement.
3.10 Limitation on
Representations . The Company shall not be deemed to have
made any representation or warranty to any Purchaser other than as
expressly made by the Company in this Section 3. Without limiting
the generality of the foregoing, except as expressly made by the
Company in this Section 3, the Company makes no representation or
warranty to the Purchaser with respect to (a) any projections,
estimates or budgets heretofore delivered or made available to the
Purchaser of future revenues, expenses or expenditures or future
results of operations or (b) any other information or documents
(financial or otherwise) made available to the Purchaser or its
counsel, accountants or advisors.
SECTION 4.
REPRESENTATIONS AND
WARRANTIES OF THE PURCHASER
The Purchaser represents and
warrants to the Company both as of the date hereof and again as of
the Closing as follows:
4.1 Investment
. The Purchaser is acquiring the Shares in the ordinary course
of its business and not with the view to, or for resale in
connection with, any distribution thereof. The Purchaser has not
offered or sold any portion of the Shares to be acquired by it and
has no present intention of reselling or otherwise disposing of any
portion of such Shares either currently or after the passage of a
fixed or determinable period of time or upon the occurrence or
nonoccurrence of any predetermined event or circumstance. The
Purchaser shall not resell the Shares in a manner that results in a
requirement to deliver a prospectus under Section 5 of the
Securities Act. The Purchaser understands that no federal or state
agency has passed upon the Shares or made any finding or
determination as t
|